Abstract
No public abstract is available from the verified source records.
Amber Lemons, Isabelle Bindseil, Danielle L. Stutzman
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
No local reference links have been materialized yet.
No local citing links have been materialized yet.
ADHD and Substance Use Disorders in Young People
2022
Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study
2018
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement
2023
Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents
2008
Stimulant ADHD medication and risk for substance abuse
2014
Early exposure to stimulant medications and substance-related problems: The role of medical and nonmedical contexts
2016
Drug Treatments for ADHD Reduce Risk of Substance Use Disorders
2017
ADHD Medication and Substance-Related Problems
2017
The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms
2020
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
2019
Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
2019
How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis
2018
Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study
2013
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate
2013
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study
2021
Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study
2016
Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
2014
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial
2015
Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders
2017
A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder
2008
Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders
2011
Five Steps to Improve Cardiac Safety of Attention Deficit Hyperactivity Disorder Treatment
2024
Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training
2020
Use of Stimulant Diversion Prevention Strategies in Pediatric Primary Care and Associations With Provider Characteristics
2021
Testing for Drugs of Abuse in Children and Adolescents
2014
No additional external references are available.